Business description
Denka Company Limited manufactures and sells organic and inorganic materials to electronic materials and pharmaceuticals in Japan and internationally. The company's Electronics & Innovative Products division provides conductive agents for lithium for lithium-ion batteries, thermal materials and substrates, functional ceramics, films, and tapes. Its Life Innovation division works to improve people's life in the fields of prevention, diagnosis, and treatment, including influenza vaccines; test reagents, such as rapid testing kits for COVID-19; and macromolecular hyaluronate preparations.
Management board & Supervisory board
| CEO |
| Toshio Imai |
| Management board |
| Kazuo Takahashi, Nobuyuki Yoshino, Kazuya Tokumoto, Hideki Takahashi, Rimiru Hayashida, Ikuo Ishida |
| Supervisory board |
| Manabu Yamamoto, Toshio Imai, Kazuo Takahashi, Ikuo Ishida, Yoshiyuki Fukuda, Uchida Mizuhiro, Toshio Kinoshita, Akio Yamamoto, Miyuki Matoba |
Company data
| Name: |
Denka Company Limited |
| Address: |
Nihonbashi Mitsui Tower,1-1,Nihonbashi-Muromachi 2-chome,Chuo-ku,Tokyo 103-8338 |
| Phone: |
+81-3-5290-5055 |
| Fax: |
+81-3-5290-5059 |
| E-mail: |
-
|
| Internet: |
https://www.denka.co.jp/eng/ |
| Industry: |
Commodities |
| Sector: |
Chemicals |
| Sub sector: |
- |
| End of financial year: |
3/31 |
| Free Float: |
- |
| IPO date: |
- |
